Free tool
Drug Trial Radar: Pain and anesthesia
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
7
Active, not recruiting, industry sponsors, Pain and anesthesia, Phase 2
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed755
7 trials
Showing 1 to 7, recently updated first.
- A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.Pivotal-lookingActive, not recruiting
PfizerPfizer (PFE)
NCT07228390 · 128 participants · Start Nov 13, 2025 · Primary completion Dec 8, 2026
Drug: Ritlecitinib; Placebo · For: Hidradenitis Suppurativa
Sites: Hot Springs, Arkansas; Fountain Valley, California; Northridge, California · 57 sites in all
- A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With EndometriosisPivotal-lookingActive, not recruiting
Gesynta Pharma ABIndustry
NCT07260669 · 213 participants · Start Oct 15, 2025 · Primary completion Jun 2027
Drug: Vipoglanstat; Placebo · For: Endometriosis
Sites: Blagoevgrad, Bulgaria; Sofia, Bulgaria; Brno, Czechia · 44 sites in all
- Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainPivotal-lookingActive, not recruiting
Dogwood Therapeutics Inc.Industry
NCT06848348 · 240 participants (planned) · Start Feb 21, 2025 · Primary completion Dec 2026
Drug: Halneuron; Placebo and 1 more · For: Chemotherapy Induced Neuropathic Pain; Chemotherapy Induced Pain Neuropathy; Chemotherapy Induced Pain
Sites: Sheffield, Alabama; Glendale, Arizona; Phoenix, Arizona · 25 sites in all
- Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainActive, not recruiting
Creative Medical Technology Holdings IncIndustry
NCT06053242 · 45 participants (planned) · Start May 21, 2024 · Primary completion Jan 20, 2027
Drug: CELZ-201-DDT · For: Chronic Low-back Pain; Degenerative Disc Disease
Sites: Aventura, Florida
- ASKC200 for Knee Osteoarthritis PainPivotal-lookingActive, not recruiting
Jiangsu Aosaikang Pharmaceutical Co., Ltd.Industry
NCT07742852 · 175 participants · Start Sep 12, 2025 · Primary completion Apr 28, 2026
Drug: 5% ASKC200; 1% Diclofenac Diethylamine Emulgel and 2 more · For: Osteoarthritis (OA) of the Knee; Pain
Sites: Beijing, China
- An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.Pivotal-lookingActive, not recruiting
Noema Pharma AGIndustry
NCT05217628 · 166 participants · Start Jan 11, 2022 · Primary completion Feb 2, 2027
Drug: Basimglurant · For: Trigeminal Neuralgia
Sites: La Jolla, California; Miami, Florida; Tampa, Florida · 34 sites in all
- Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA PainPivotal-lookingActive, not recruiting
Paradigm Biopharmaceuticals USA (INC)Industry
NCT04809376 · 602 participants · Start Oct 19, 2021 · Primary completion Oct 15, 2024
Drug: Pentosan Polysulfate Sodium twice weekly; Placebo (Sodium Chloride Injection, 0.9%) and 2 more · For: Osteoarthritis, Knee
Sites: Tempe, Arizona; Tucson, Arizona; Cerritos, California · 33 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.